Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
XS-005 by XellSmart Biomedical (Shanghai) for Glioblastoma Multiforme (GBM): Likelihood of Approval
XS-005 is under clinical development by XellSmart Biomedical (Shanghai) and currently in Phase II for Glioblastoma Multiforme (GBM). According to...